,Gene,Histology,Mutation,Exon,Effect
0,SRSF2,Lymph-BNHL,chr17:g.74733234G>A,2,within 20bp of 3 prime splicing site
0,ACTA1,Lymph-CLL,chr1:g.229567630A>G,6,within 20bp of 5 prime splicing site
0,ACTA1,Lymph-CLL,chr1:g.229567636C>A,6,within 20bp of 5 prime splicing site
0,ACTA1,Lymph-CLL,chr1:g.229567639C>A,6,within 20bp of 5 prime splicing site
0,SIGLEC15,Panc-AdenoCA,chr18:g.43418687G>C,4,within 20bp of 5 prime splicing site
0,RTN4,Liver-HCC,chr2:g.55200752C>T,6,within 20bp of 5 prime splicing site
0,SH3BGR,Panc-Endocrine,chr21:g.40834315G>A,3,within 20bp of 5 prime splicing site
0,ACVRL1,Prost-AdenoCA,chr12:g.52307539C>T,4,within 20bp of 3 prime splicing site
0,ACVRL1,Prost-AdenoCA,chr12:g.52307549T>C,4,within 20bp of 3 prime splicing site
0,SOX18,Eso-AdenoCA,chr20:g.62680308C>T,2,within 20bp of 5 prime splicing site
0,NCAN,Biliary-AdenoCA,chr19:g.19351488C>T,12,within 20bp of 3 prime splicing site
